Thor Ostenfeld, PhD, MBA

Head of Clinical Development
Grünenthal
Aachen, Nordrhein-Westfalen, Germany

Dr. Thor Ostenfeld is the Head of Clinical Development at Grünenthal.

Disclosure information not submitted.

Presentation(s):

• P-020 - First-in-Human Study of the TRPV1 Agonist RTX-GRT7039 for Knee Osteoarthritis Pain

  POSTER ABSTRACT

• P-022 - Safety and Analgesic Effect of the TRPV1 Agonist RTX-GRT7039 in Osteoarthritis Knee Pain

  POSTER ABSTRACT